Recent Finacing
Recent Raise
Navitor develops small-molecule therapeutics targeting the mTOR kinase pathway, conducting preclinical characterization across Huntington's, rare diseases, and chronic indications while progressing multiple programs toward clinical testing.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors